No Data
No Data
Enprex Announces Strategic CDMO Collaboration For Diabetes Gene Therapy Using Non-Viral Delivery System
Genprex Strengthens Diabetes Focus With New License
Genprex Announces Amended License Agreement With University Of Pittsburgh For Gene Therapy Technologies In Diabetes; Forms Subsidiary Convergen Biotech For Diabetes Program Development
Express News | Genprex Inc - to Seek FDA Guidance for Ind Application in 2025
Express News | Genprex Inc - Forms Wholly-Owned Subsidiary, Convergen Biotech
Express News | Genprex Inc - Signs New Exclusive License Agreement With University of Pittsburgh of Commonwealth System of Higher Education
Unlock the Full List